Cite
HARVARD Citation
George, J. et al. (2018). Rapid Development of High-Level Resistance to Dolutegravir With Emergence of T97A Mutation in 2 Treatment-Experienced Individuals With Baseline Partial Sensitivity to Dolutegravir. Open forum infectious diseases. p. . [Online].